209 related articles for article (PubMed ID: 32980333)
21. Endocannabinoid regulation of homeostatic feeding and stress-induced alterations in food intake in male rats.
Sticht MA; Lau DJ; Keenan CM; Cavin JB; Morena M; Vemuri VK; Makriyannis A; Cravatt BF; Sharkey KA; Hill MN
Br J Pharmacol; 2019 May; 176(10):1524-1540. PubMed ID: 30051485
[TBL] [Abstract][Full Text] [Related]
22. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
Spradley JM; Guindon J; Hohmann AG
Pharmacol Res; 2010 Sep; 62(3):249-58. PubMed ID: 20416378
[TBL] [Abstract][Full Text] [Related]
23. Impact of tetrahydrocannabinol on the endocannabinoid 2-arachidonoylglycerol metabolism: ABHD6 and ABHD12 as novel players in human placenta.
Maia J; Fonseca BM; Cunha SC; Braga J; Gonçalves D; Teixeira N; Correia-da-Silva G
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158807. PubMed ID: 32829065
[TBL] [Abstract][Full Text] [Related]
24. Fatty pain cures.
Imming P
Chem Biol; 2007 Dec; 14(12):1311-2. PubMed ID: 18096498
[TBL] [Abstract][Full Text] [Related]
25. Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis.
Pulgar VM; Yamaleyeva LM; Varagic J; McGee CM; Bader M; Dechend R; Howlett AC; Brosnihan KB
Hypertension; 2014 Sep; 64(3):619-25. PubMed ID: 24935942
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
Walentiny DM; Vann RE; Wiley JL
Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
[TBL] [Abstract][Full Text] [Related]
28. New insights into endocannabinoid degradation and its therapeutic potential.
Bari M; Battista N; Fezza F; Gasperi V; Maccarrone M
Mini Rev Med Chem; 2006 Mar; 6(3):257-68. PubMed ID: 16515464
[TBL] [Abstract][Full Text] [Related]
29. Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications.
Pertwee RG
Proc Nutr Soc; 2014 Feb; 73(1):96-105. PubMed ID: 24135210
[TBL] [Abstract][Full Text] [Related]
30. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
Kinsey SG; Long JZ; O'Neal ST; Abdullah RA; Poklis JL; Boger DL; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2009 Sep; 330(3):902-10. PubMed ID: 19502530
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice.
Nozaki C; Markert A; Zimmer A
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1388-96. PubMed ID: 25910421
[TBL] [Abstract][Full Text] [Related]
32. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase.
Reggio PH; Traore H
Chem Phys Lipids; 2000 Nov; 108(1-2):15-35. PubMed ID: 11106780
[TBL] [Abstract][Full Text] [Related]
33. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
De Petrocellis L; Ligresti A; Moriello AS; Allarà M; Bisogno T; Petrosino S; Stott CG; Di Marzo V
Br J Pharmacol; 2011 Aug; 163(7):1479-94. PubMed ID: 21175579
[TBL] [Abstract][Full Text] [Related]
34. Induction of endocannabinoid levels in juvenile rat brain following developmental chlorpyrifos exposure.
Carr RL; Adams AL; Kepler DR; Ward AB; Ross MK
Toxicol Sci; 2013 Sep; 135(1):193-201. PubMed ID: 23761300
[TBL] [Abstract][Full Text] [Related]
35. N-Stearoyltyrosine protects primary cortical neurons against Aβ(1-40)-induced injury through inhibiting endocannabinoid degradation.
Cui H; Yang R; Liu S; Fu G; Lu Y
Life Sci; 2015 Mar; 124():91-100. PubMed ID: 25637682
[TBL] [Abstract][Full Text] [Related]
36. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
[TBL] [Abstract][Full Text] [Related]
37. Perinatal maternal high-fat diet induces early obesity and sex-specific alterations of the endocannabinoid system in white and brown adipose tissue of weanling rat offspring.
Almeida MM; Dias-Rocha CP; Souza AS; Muros MF; Mendonca LS; Pazos-Moura CC; Trevenzoli IH
Br J Nutr; 2017 Nov; 118(10):788-803. PubMed ID: 29110748
[TBL] [Abstract][Full Text] [Related]
38. The antinociceptive triterpene β-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting cannabinoid receptors.
Chicca A; Marazzi J; Gertsch J
Br J Pharmacol; 2012 Dec; 167(8):1596-608. PubMed ID: 22646533
[TBL] [Abstract][Full Text] [Related]
39. Biological evaluation of pyridone alkaloids on the endocannabinoid system.
Chicca A; Berg R; Jessen HJ; Marck N; Schmid F; Burch P; Gertsch J; Gademann K
Bioorg Med Chem; 2017 Nov; 25(22):6102-6114. PubMed ID: 28284861
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of single versus repeated alcohol withdrawal on the expression of endocannabinoid system-related genes in the rat amygdala.
Serrano A; Rivera P; Pavon FJ; Decara J; Suárez J; Rodriguez de Fonseca F; Parsons LH
Alcohol Clin Exp Res; 2012 Jun; 36(6):984-94. PubMed ID: 22141465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
